Tag Archives: Chakrabarty

USPTO Subject Matter Eligibility Guidance – 9th May Forum – Outcome and Opportunities

Posted on May 16, 2014 by Warren Woessner

Guest Post from Paul Cole, Lucas & Co., UK As noted in postings in this and other blogs, controversy has been generated by the publication of new USPTO patent eligibility guidance for laws of nature, natural products and natural phenomena (Andrew … Continue reading →

Posted in Forum | Tagged , , , , , , , | 1 Comment

In re Bergstrom – A Lost Precedent That Should Be “Found”

Posted on May 2, 2014 by Warren Woessner

Since I do a lot of commentary, I read a lot of commentary, and have been struck by how the PTO s. 101 Guidelines on “Laws of Nature” have been criticized as if they are free from the constraints of … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | Leave a comment

USPTO s.101 Guidelines – How to “Eviscerate Patent Law”

Posted on March 27, 2014 by Warren Woessner

On March 19th, the USPTO released 93 slides as training materials to help Examiners navigate the lengthy ”Guidelines for Subject Matter Eligibility Analysis of Claims Reciting or Involving Laws of Nature,” et al. (A copy of the slides is available … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 1 Comment

AMP Petitions for Cert. and A Look Back

Posted on December 16, 2011 by Warren Woessner

The Association for Molecular Pathology (AMP) has petitioned the Supreme Court to review the Fed. Cir.’s opinion of July 29th, that isolated BRCA DNA sequences are patentable subject matter. Its brief (a copy available at the end of this post) … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , , , , | 1 Comment